The roles of toll-like receptor 9, MyD88, and DNA-depondent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets

被引:266
作者
Hemmi, H
Kaisho, T
Takeda, K
Akira, S
机构
[1] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan
[2] Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Suita, Osaka, Japan
[3] RIKEN, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan
关键词
D O I
10.4049/jimmunol.170.6.3059
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oligodeoxynucleotides containing unmethylated CpG motifs (CpG DNAs) can function as powerful immune adjuvants by activating APC. Compared with conventional phosphorothioate-backbone CpG DNAs, another type of CpG DNAs, called an A or D type (A/D-type), possesses higher ability to induce IFN-alpha production. Conventional CpG DNAs can exert their activity through Toll-like receptor 9 (TLR9) signaling, which depends on a cytoplasmic adapter, MyD88. However, it remains unknown how A/D-type CpG DNAs exhibit their immunostimulatory function. In this study we have investigated murine dendritic cell (DC) responses to these two distinct CpG DNAs. Not only splenic, but also in vitro bone marrow-derived, DCs could produce larger amounts of IFN-alpha in response to A/D-type CpG DNAs compared with conventional CpG DNAs. This IFN-alpha production was mainly due to the B220(+) DC subset. On the other hand, the B220(-) DC subset responded similarly to both CpG DNAs in terms of costimulatory molecule up-regulation and IL-12 induction. IFN-alpha, but not IL-12, induction was dependent on type I IFN. However, all activities of both CpG DNAs were abolished in TLR9- and MyD88-, but were retained in DNA-PKcs-deficient DCs. This study demonstrates that the TLR9-MyD88 signaling pathway is essential for all DC responses to both types of CpG DNAs.
引用
收藏
页码:3059 / 3064
页数:6
相关论文
共 38 条
  • [1] Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
    Adachi, O
    Kawai, T
    Takeda, K
    Matsumoto, M
    Tsutsui, H
    Sakagami, M
    Nakanishi, K
    Akira, S
    [J]. IMMUNITY, 1998, 9 (01) : 143 - 150
  • [2] Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO
  • [3] 2-U
  • [4] Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology
    Asselin-Paturel, C
    Boonstra, A
    Dalod, M
    Durand, I
    Yessaad, N
    Dezutter-Dambuyant, C
    Vicari, A
    O'Garra, A
    Biron, C
    Brière, F
    Trinchieri, G
    [J]. NATURE IMMUNOLOGY, 2001, 2 (12) : 1144 - 1150
  • [5] Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs
    Ballas, ZK
    Krieg, AM
    Warren, T
    Rasmussen, W
    Davis, HL
    Waldschmidt, M
    Weiner, GJ
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (09) : 4878 - 4886
  • [6] Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
    Bauer, S
    Kirschning, CJ
    Häcker, H
    Redecke, V
    Hausmann, S
    Akira, S
    Wagner, H
    Lipford, GB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) : 9237 - 9242
  • [7] Interferons α and β as immune regulators -: A new look
    Biron, CA
    [J]. IMMUNITY, 2001, 14 (06) : 661 - 664
  • [8] RETRACTED: DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA (Retracted Article)
    Chu, WM
    Gong, X
    Li, ZW
    Takabayashi, K
    Ouyang, HH
    Chen, Y
    Lois, A
    Chen, DJ
    Li, GC
    Karin, M
    Raz, E
    [J]. CELL, 2000, 103 (06) : 909 - 918
  • [9] A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination
    Gao, YJ
    Chaudhuri, J
    Zhu, CM
    Davidson, L
    Weaver, DT
    Alt, FW
    [J]. IMMUNITY, 1998, 9 (03) : 367 - 376
  • [10] The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor
    Gilliet, M
    Boonstra, A
    Paturel, C
    Antonenko, S
    Xu, XL
    Trinchieri, G
    O'Garra, A
    Liu, YJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) : 953 - 958